We're still accepting applications for fall 2025!
Apply Today
The national vaccine strategy paid for itself after just one year, according to a study led by University of Michigan researchers. The United States prevented far more in medical spending and lost productivity than it spent on testing, buying and delivering the 2021 vaccines.
Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.
Economic model created for CDC shows that in older adults promoting updated vaccination will save the US money, while in other adults it should be reasonably cost effective.
David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).
Michigan Public Health researchers were awarded a $2.2M grant to research the relationship between illegal dumping and community violence.
Adding the hurdle of vaccine education prior to obtaining a nonmedical exemption may improve vaccination rates in the short term, but policymakers may want to consider more holistic strategies to change parental behaviors in the long term, according to a new University of Michigan study.